例如:"NBL1", "4681", "drought"
收藏
54765 TRIM44

54765

TRIM44

tripartite motif containing 44

protein-coding

Homo sapiens

基因描述

Type Description
Definition tripartite motif containing 44

研究结论

Date Results Publications
2021-03-20 13:30:00 Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer. 32271433
2021-02-06 13:53:00 Knockdown of HIF1A-AS2 suppresses TRIM44 to protect cardiomyocytes against hypoxia-induced injury. 32222118
2021-01-23 12:59:00 Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis. 32503466
2020-12-05 13:04:00 ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis. 31929141
2020-11-21 13:23:00 miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44. 31873114

名称对应

Type IDs
Synonymous AN3, DIPB, HSA249128, MC7
Gene
UniProtKB-ID: TRI44_HUMAN
UniprotKB: Q96DX7
UniParc: UPI00000725C5
EMBL: CH471064, AL138812, BC024031, AJ249128, BC013166
Ensembl: ENSG00000166326
KO: hsa:54765
Nucleutide sequences
EMBL-CDS: AAH24031.1, CAB65108.1, EAW68134.1, AAH13166.1, EAW68133.1
Ensembl_TRS: ENST00000299413
Protein sequencees
Ensembl_PRO: ENSP00000299413
RefSeq: XP_006718317.1, NP_060053.2
Others
UniRef100: UniRef100_Q96DX7
UniRef90: UniRef90_Q96DX7
UniRef50: UniRef50_Q96DX7
UniGene: Hs.192103
CCDS: CCDS31461.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员